MALACRIDA ALESSIO

Melgari, D., Calamaio, S., Frosio, A., Prevostini, R., Malacrida, A., Anastasia, L., et al. (2026). Electrophysiological mechanisms behind the differential cardiotoxicity of chemotherapeutic agents Bortezomib and Carfilzomib. FRONTIERS IN DRUG DISCOVERY, 6, 1-14 [10.3389/fddsv.2026.1774061]. Dettaglio

Rivara, M., Malacrida, A., Ghizzi, M., Bentivegna, A., Sica, F., Re, F., et al. (2026). Design and Biological Evaluation of ALKBH2 and ALKBH5 Inhibitors as Adjuvants to Temozolomide-Based Glioblastoma Treatment. BIOLOGY, 15(16) [10.3390/biology15161371]. Dettaglio

Invernizzi, C., Di Girolamo, S., Malacrida, A., Rodriguez-Menendez, V., Housley, S., Alberti, P. (2026). Role of the Sodium–Calcium Exchanger NCX2 in Oxaliplatin-Induced Peripheral Neurotoxicity. In The Congress Book of the First SINS Young Meeting (pp.38). Dettaglio

Cavaletti, G., Canta, A., Chiorazzi, A., Ballarini, E., Rodriguez, V., Scuteri, A., et al. (2026). Protective effect of new histone deacetylase 6 inhibitors in a cisplatin-induced peripheral neurotoxicity murine model. PAIN REPORTS, 11(2) [10.1097/PR9.0000000000001395]. Dettaglio

Invernizzi, C., Di Girolamo, S., Malacrida, A., Rodriguez-Menendez, V., Mauri, M., Housley, S., et al. (2026). Sodium-Calcium Exchanger NCX2 Role in Oxaliplatin Induced Peripheral Neurotoxicity Development. Intervento presentato a: FENS Forum 2026, Barcelona, Spain. Dettaglio